With populations around the world getting older, demand for healthcare services is expected to grow materially over the next couple of decades.
In light of this, I think the healthcare sector is a great place to look for long term investment options.
Two quality ASX healthcare shares that tick a lot of boxes for me are listed below. Here’s why I think they could be great options:
iShares Global Healthcare ETF (ASX: IXJ)
The first healthcare option for investors to consider is actually an exchange traded fund (ETF). I think the iShares Global Healthcare ETF would be a fantastic option due to the large number of quality companies that it is invested in. It provides investors with exposure to healthcare companies across a range of sectors including biotechnology, pharmaceutical, and medical devices.
This means investors will be investing in many of the world’s biggest healthcare companies such as CSL Limited (ASX: CSL), Johnson & Johnson, Novartis, and Pfizer. I believe this group of companies has the potential to outperform the market over the long term thanks to the favourable industry tailwinds. As a result, I feel the iShares Global Healthcare ETF could be a great long term option.
Ramsay Health Care Limited (ASX: RHC)
Another option for investors to consider buying is Ramsay Health Care. This private hospital operator has been facing tough trading conditions for a couple of years and things are unlikely to get easier in the immediate term. But I wouldn’t let that put you off investing with a long term view. Especially given how this appears to have already being factored into the Ramsay share price.
I believe Ramsay’s long term outlook is very positive. This is due to the aforementioned forecasted increase in demand for healthcare services and its global footprint. Another positive is that Ramsay’s management team has a track record of accelerating its growth through acquisitions. I suspect there will be further acquisitions in the coming years that expand its footprint into new markets and drive further growth.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- ASX 200 rises 0.7%, CSL soars 6.4%
- How will the University of Oxford’s COVID-19 vaccine impact ASX share prices?
- ASX 200 up 0.8%: ANZ to pay dividend, a2 Milk tumbles, CSL impresses
- Why Corp Travel, CSL, Domino’s, & WiseTech Global shares are storming higher
- The latest ASX stocks upgraded by brokers to “buy” today
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Why I would buy and hold these ASX healthcare shares until 2040 appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3g7K5ux
Leave a Reply